Reported Reactions

Devices › Counter, differential cell

Device brand name · Automated hematology analyzer

Cell-Dyn 1800 Analyzer: medical device reports filed with FDA

377 reports name it, 2008–2017. Manufacturer given most often on reports: Abbott Diagnostics Division. Product code GKZ.

377
device reports naming the brand
0% of all MAUDE reports · about 21 a year
0
reports, 12 months to August 2026
0 in the 12 months before
99.2%
classified as malfunction
95.7% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

377 medical device reports received by FDA name the brand "Cell-Dyn 1800 Analyzer" (automated hematology analyzer); the manufacturer given most often on reports is Abbott Diagnostics Division; received from May 2008 to December 2017. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.2%) and injury (0.8%); across all counter, differential cell reports (product code GKZ) death is recorded in 0.1% and malfunction in 95.7%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are incorrect or inadequate test results (17%), low test results (16.2%) and sensor problems (15.9%). The patient problems coded most often are no patient involvement, venipuncture and chemical exposure. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

No report naming Cell-Dyn 1800 Analyzer was received in the five years to August 2026; the latest was received in December 2017.

By year received

0811612008: 5720082009: 16120092010: 7120102011: 4320112012: 1620122013: 720132015: 1020152016: 820162017: 42017

Event type and report source

Event type, as classified on the report

Death0%0
Injury0.8%3
Malfunction99.2%374
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%377
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 23,441 reports carrying product code GKZ. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Incorrect or inadequate test results6417%8.9%
Low test results6116.2%16.5%
Sensor problems6015.9%0.4%
Component incompatible4612.2%0.2%
Fluid/blood leak205.3%29.2%
High test results195%5.3%
Leak/splashthe device leaked154%13.8%
Breakthe device broke143.7%1%
Device displays incorrect message123.2%6.1%
Device alarm system112.9%0.8%
Installation-related problem112.9%0.1%
Imprecision82.1%0.1%
Device sensing problem71.9%0.2%
Overfill61.6%0.4%
Failure to sense51.3%0.1%
Improper or incorrect procedure or method51.3%0.3%
Smoking41.1%1%
Air leak30.8%0.2%
Corrodedthe device corroded20.5%0%
Device contamination with chemical or other material20.5%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
No patient involvement102.7%
Venipuncture20.5%
Chemical exposure10.3%
Electric shockan electric shock10.3%
Peritonitis10.3%
Test result10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureCell-Dyn 1800 AnalyzerProduct code GKZAll MAUDE reports
Reports37723,44126,136,888
Share of that pool—1.6%0%
Classified as death, per 1,000 reports019
Classified as injury0.8%1.4%36.2%
Classified as malfunction99.2%95.7%62.3%
Filed by the manufacturer100%99.6%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code GKZ

BrandReportsLatest 12 monthsClassified as death
Coulter Lh 750 Hematology Analyzer2,73000%
Cell-Dyn Emerald Cleaner2,22900%
Coulter Lh 500 Hematology Analyzer2,01600%
Coulter Lh 780 Hematology Analyzer1,61400%
Unicel Dxh 800 Coulter Cellular Analysis System1,59100%
Fc 500 Flow Cytometer1,19800%
Coulter Hmx Hematology Analyzer With Autoloader75500%
Cell-Dyn Sapphire Analyzer63600%
Coulter Act Diff 2 Analyzer53600%
Cell-Dyn Wbc Reagent A51900%
Coulter Act Diff Analyzer48000%
Cell-Dyn Ruby Analyzer45800.7%
Coulter Ac T Diff Analyzer44900%
Coulter Ac T Diff 2 Analyzer42500%
Coulter Lh750 Hematology Analyzer34700%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Cell-Dyn 1800 Analyzer reports

How many FDA reports name Cell-Dyn 1800 Analyzer?

377 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.

What kinds of events are reported?

malfunction (99.2%) and injury (0.8%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

incorrect or inadequate test results (17%), low test results (16.2%), sensor problems (15.9%), component incompatible (12.2%) and fluid/blood leak (5.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Cell-Dyn 1800 Analyzer was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.